MarketAnalysisMarketAnalysis
NYSE:ELV

Elevance Health, Inc. - NYSE:ELV - Comprehensive analysis

Free evaluation through quantitative algorithms Elevance Health, Inc. - NYSE:ELV

Quant Rating

1

Strong Sell

2

Sell

3

Hold

4

Buy

5

Strong Buy


The overall quant rating is not an average of the factor grades listed.Instead, it gives greater weight to the metrics with the strongest predictive value.

Growth-Scoring Model Detail

Name

Fatcor
Percentage

Total Revenue Growth Over Prior Year

3.19

Market

43

Sector

51

Gross Profit Growth Over Prior Year

4.75

Market

45

Sector

53

EBITDA Growth Over Prior Year

-9.98

Market

11

Sector

19

EBITA Growth Over Prior Year

-9.25

Market

15

Sector

23

EBIT Growth Over Prior Year

-7

Market

18

Sector

24

Earnings from Cont. Ops. Growth Over Prior Year

-0.33

Market

40

Sector

39

Net Income Growth Over Prior Year

-0.12

Market

40

Sector

41

Normalized Net Income Growth Over Prior Year

-9.33

Market

19

Sector

21

Diluted EPS before Extra Growth Over Prior Year

1.82

Market

42

Sector

42

A/R Growth Over Prior Year

1.38

Market

49

Sector

61

Inventory Growth Over Prior Year

0

Market

66

Sector

48

PPE Net Growth Over Prior Year

5.58

Market

64

Sector

72

Total Assets Growth Over Prior Year

7.31

Market

72

Sector

65

Tangible Book Value Growth Over Prior Year

-74.6

Market

2

Sector

5

Common Equity Growth Over Prior Year

5.11

Market

51

Sector

63

Cash from Ops. Growth Over Prior Year

-27.95

Market

11

Sector

17

CAPEX Growth Over Prior Year

-3.09

Market

31

Sector

46

Dividend per Share Growth Over Prior Year

10.14

Market

82

Sector

99

Levered Free Cash Flow Growth Over Prior Year

1008

Market

100

Sector

100

Unlevered Free Cash Flow Growth Over Prior Year

504

Market

99

Sector

98

Profitability-Scoring Model Detail

Name

Fatcor
Percentage

Gross Margin %

27.9

Market

25

Sector

37

SG&A Margin %

22.3

Market

70

Sector

35

EBITDA Margin %

5.57

Market

7

Sector

65

EBITA Margin %

5.53

Market

15

Sector

68

EBIT Margin %

5.2

Market

9

Sector

69

Earnings from Cont. Ops Margin %

3.38

Market

13

Sector

76

Net Income Margin %

3.38

Market

13

Sector

77

Net Income Avail. for Common Margin %

3.38

Market

13

Sector

77

Normalized Net Income Margin %

2.84

Market

10

Sector

73

Levered Free Cash Flow Margin %

3.91

Market

30

Sector

66

Unlevered Free Cash Flow Margin %

4.33

Market

27

Sector

65

Return on Assets %

5.09

Market

48

Sector

85

Return on Capital %

8.01

Market

50

Sector

88

Return on Equity %

14.77

Market

49

Sector

89

Return on Common Equity %

14.83

Market

49

Sector

89

Total Asset Turnover

1.57

Market

95

Sector

97

Sub-Scoring Model

Valuation
Momentum
Growth
Profitability
80
60
40
20
Valuation: 75
Momentum: 32
Growth: 45
Profitability: 33

Valuation-Scoring Model Detail

Name

Fatcor
Percentage

TEV/LTM Total Revenue

0.6

Market

5

Sector

11

TEV/LTM EBITDA

10.98

Market

33

Sector

43

P/LTM Normalized EPS

18.11

Market

21

Sector

30

P/BV

2.05

Market

30

Sector

50

TEV/LTM Unlevered FCF

13.37

Market

14

Sector

37

Momentum-Scoring Model Detail

Name

Fatcor
Percentage

1M Price Performance

3.19

Market

70

Sector

48

3M Price Performance

-8.24

Market

15

Sector

47

6M Price Performance

-0.51

Market

59

Sector

73

9M Price Performance

-28.33

Market

7

Sector

48

1Y Price Performance

-27.47

Market

9

Sector

53

Start analyzing Elevance Health, Inc. - NYSE:ELV with easy-to-understand research reports

Start analyzing Recent popular companies with easy-to-understand research reports